Episode Description
In this episode, we explore extended-release naltrexone for opioid use disorder, examining its unique role as a pure antagonist in patients who require safety-sensitive careers. How do we successfully navigate the challenging initiation period when patients must be opioid-free for a week?
Faculty: Smita Das, M.D.
Host: Richard Seeber, M.D.